Effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: a randomized controlled trial
Maguy Saffouh El Hajj, Nadir Kheir, Ahmad Mohd Al Mulla, Rula Shami, Nadia Fanous, Ziyad R Mahfoud, Maguy Saffouh El Hajj, Nadir Kheir, Ahmad Mohd Al Mulla, Rula Shami, Nadia Fanous, Ziyad R Mahfoud
Abstract
Background: Cigarette smoking is one of the major preventable causes of death and diseases in Qatar. The study objective was to test the effect of a structured smoking cessation program delivered by trained pharmacists on smoking cessation rates in Qatar.
Methods: A prospective randomized controlled trial was conducted in eight ambulatory pharmacies in Qatar. Eligible participants were smokers 18 years and older who smoked one or more cigarettes daily for 7 days, were motivated to quit, able to communicate in Arabic or English, and attend the program sessions. Intervention group participants met with the pharmacists four times at 2 to 4 week intervals. Participants in the control group received unstructured brief smoking cessation counseling. The primary study outcome was self-reported continuous abstinence at 12 months. Analysis was made utilizing data from only those who responded and also using intent-to-treat principle. A multinomial logistic regression model was fitted to assess the predictors of smoking at 12 months. Analysis was conducted using IBM-SPSS® version 23 and STATA® version 12.
Results: A total of 314 smokers were randomized into two groups: intervention (n = 167) and control (n = 147). Smoking cessation rates were higher in the intervention group at 12 months; however this difference was not statistically significant (23.9% vs. 16.9% p = 0.257). Similar results were observed but with smaller differences in the intent to treat analysis (12.6% vs. 9.5%, p = 0.391). Nevertheless, the daily number of cigarettes smoked for those who relapsed was significantly lower (by 4.7 and 5.6 cigarettes at 3 and 6 months respectively) in the intervention group as compared to the control group (p = 0.041 and p = 0.018 respectively). At 12 months, the difference was 3.2 cigarettes in favor of the intervention group but was not statistically significant (p = 0.246). Years of smoking and daily number of cigarettes were the only predictors of smoking as opposed to quitting at 12 months (p = 0.005; p = 0.027 respectively).
Conclusions: There was no statistically significant difference in the smoking cessation rate at 12 months between the groups. However, the smoking cessation program led to higher (albeit non-significant) smoking cessation rates compared with usual care. More research should be conducted to identify factors that might improve abstinence.
Trial registration: Clinical Trials NCT02123329 . Registration date 20 April 2014.
Keywords: Intervention; Pharmacist; Qatar; Randomized controlled trial; Smoking cessation; Tobacco cessation.
Figures
References
- The World Health Organization. Tobacco factsheet. . Accessed 2 Sept 2016.
- The World Health Organization. Report on the Global Tobacco Epidemic, 2011:warning about the dangers of tobacco. . (2011). Accessed 2 Sept 2016.
- The World Health Organization. Fact sheet about health benefits of smoking cessation. . (2015). Accessed 22 May 2016.
- The World Health Organization. Tobacco Free Initiative (TFI). . Accessed 22 May 2016.
- U.S. Department of Health and Human Services. Treating tobacco use and dependence: 2008 update.2008. . Accessed 22 May 2016.
- Aquilino ML, Farris KB, Zillich AJ, Lowe JB. Smoking-cessation services in Iowa community pharmacies. Pharmacotherapy. 2003;23:666–73. doi: 10.1592/phco.23.5.666.32192.
- Saba M, Diep J, Saini B, Dhippayom T. Meta-analysis of the effectiveness of smoking cessation interventions in community pharmacy. J Clin Pharm Ther. 2014;39:240–7. doi: 10.1111/jcpt.12131.
- Vial RJ, Jones TE, Ruffin RE, Gilbert AL. Smoking cessation program using nicotine patches: linking hospital to the community. J Pharm Pract Res. 2002;32:57–62. doi: 10.1002/jppr200232157.
- Carroll P, Rois R, Sarson D, Flynn J. A community pharmacy based smoking cessation program using transdermal nicotine replacement therapy: actions and outcomes. Aust Pharmacist. 2000;19:51–5.
- Zillich AJ, Ryan M, Adams A, Yeager B, Farris K. Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality of life. Pharmacotherapy. 2002;22:759–65. doi: 10.1592/phco.22.9.759.34073.
- Dent LA, Harris KJ, Noonan CW. Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation. Ann Pharmacother. 2009;43:194–201. doi: 10.1345/aph.1L556.
- Smith MD, McGhan WF, Lauger G. Pharmacist counseling and outcomes of smoking cessation. Am Pharm. 1995;NS35:20–9. doi: 10.1016/S0160-3450(15)30095-7.
- Kennedy DT, Giles JT, Chang ZG, Small RE, Edwards JH. Results of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc. 2002;42:51–6. doi: 10.1331/108658002763538071.
- Dent LA, Scott JG, Lewis E. Pharmacist-managed tobacco cessation program in Veterans Health Administration community-based outpatient clinic. J Am Pharm Assoc. 2004;44:700–15. doi: 10.1331/1544345042467290.
- The International Pharmaceutical Federation. FIP Statement of Policy: the Role of the Pharmacist in Promoting a Tobacco Free Future. (2003). Accessed 22 May 2016.
- Europharm Forum. Pharmacists and Actions on Tobacco. (1998). Accessed 22 May 2016.
- Hudmon KS, Corelli RL. ASHP therapeutic position statement on the cessation of tobacco Use. Am J Health Syst Pharm. 2009;66:291–307. doi: 10.2146/ajhp070303.
- The World Health Organization. Global Adult Tobacco Survey Qatar. (2013). Accessed 22 May 2016.
- The World Health Organization. Global Youth Tobacco Survey Qatar. (2014). Accessed 22 May 2016.
- The World Health Organization. Qatar: WHO Statistical Profile. (2015). Accessed 22 May 2016.
- Bener A, Ayub H, Kakil R, Ibrahim W. Patterns of cancer incidence among the population of Qatar: a worldwide comparative study. Asian Pac J Cancer Prev. 2008;9:19–24.
- Smoking—Addressing a National Epidemic. Available at: . Accessed 22 May 2016.
- Supreme Council of Health. TOBACCO CESSATION ACTION PLAN: (2015–2016). . Accessed 22 May 2016.
- El Hajj MS, Al Nakeeb RR, Al-Qudah RA. Smoking cessation counseling in Qatar: community pharmacists’ attitudes, role perceptions and practices. Int J Clin Pharm. 2012;34:667–76. doi: 10.1007/s11096-012-9663-x.
- El Hajj MS, Kheir N, Al Mulla AM, Al-Badriyeh D, Al Kaddour A, Mahfoud ZR, et al. Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial. Trials. 2015;16:65. doi: 10.1186/s13063-015-0570-z.
- UpToDate. Behavioral approaches to smoking cessation. . Accessed 22 May 2016.
- Kennedy DT, Small RE. Development and implementation of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc. 2002;42:83–92. doi: 10.1331/108658002763538116.
- Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict. 1991;86:1119–27. doi: 10.1111/j.1360-0443.1991.tb01879.x.
- Al Mohamed HI, Amin TT. Pattern and prevalence of smoking among students at King Faisal University, Al Hassa. Saudi Arabia EMHJ. 2010;16:56–64.
- Asfar MD, Vander MW, Maziak W, Hammal F, Eissenberg T, Ward KD. Outcomes and adherence in Syria’s first smoking cessation trial. Am J Health Behav. 2008;32:146–56. doi: 10.5993/AJHB.32.2.4.
- Hudmon KS, Berger BA. Pharmacy applications of the transtheoretical model in smoking cessation. Am J Health Syst Pharm. 1995;52:282–7.
- DRUGDEX® Evaluations. Nicotine. . Accessed 22 May 2016.
- DRUGDEX® Evaluations: Nicotine polacrilex. . Accessed 22 May 2016.
- Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med. 2001;163:1693–1722. doi: 10.1164/ajrccm.163.7.2009041.
- Schulz KF, Altman DG, Moher D, for the CONSORT Group CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. doi: 10.1136/bmj.c332.
- Borelli B, Hogan J, Bock B, Pinto B, Roberts M, Marcus B. Predictors of quitting and dropout among women in a clinic-based smoking cessation program. Psychol Addict Behav. 2002;16:22–7. doi: 10.1037/0893-164X.16.1.22.
- Maguire TA, McElnay JC, Drummond A. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction. 2001;96:325–31. doi: 10.1046/j.1360-0443.2001.96232516.x.
- Sinclair HK, Bond CM, Lennox AS, Silcock J, Winfield AJ, Donnan PT. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomized controlled trial in Scotland. Tob Control. 1998;7:253–61. doi: 10.1136/tc.7.3.253.
- Thomas D, Abramson MJ, Bonevski B, Taylor S, Poole SG, Paul E, et al. Integrating smoking cessation into routine care in hospitals-a randomized controlled trial. Addiction. 2016;111:714–23. doi: 10.1111/add.13239.
- El Hajj MS, Al-Saeed HS, Khaja M. Qatar pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care. Int J Clin Pharm. 2016;38:330–43. doi: 10.1007/s11096-016-0246-0.
- Vangeli E, Stapleton J, Smit ES, Borland R, West R. Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction. 2011;106:2110–21. doi: 10.1111/j.1360-0443.2011.03565.x.
- Bauld L, Boyd KA, Briggs AH, Chesterman J, Ferguson J, Judge K, et al. One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services. Nicotine Tob Res. 2011;13:135–45. doi: 10.1093/ntr/ntq222.
- Roth MT, Westman EC. Use of bupropion SR in a pharmacist-managed outpatient smoking-cessation program. Pharmacotherapy. 2001;21:636–41. doi: 10.1592/phco.21.6.636.34548.
- Hyland A, Li Q, Bauer JE, Giovino GA, Steger C, Cummings KM. Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine Tob Res. 2004;6(Suppl 3):S363–9. doi: 10.1080/14622200412331320761.
- Khan N, Anderson JR, Du J, Tinker D, Bachyrycz AM, Namdar R. Smoking cessation and its predictors: results from a community-based pharmacy tobacco cessation program in New Mexico. Ann Pharmacother. 2012;46:1198–204. doi: 10.1345/aph.1P146.
- Shen X, Bachyrycz A, Anderson JR, Tinker D, Raisch DW. Quitting patterns and predictors of success among participants in a tobacco cessation program provided by pharmacists in New Mexico. J Manag Care Spec Pharm. 2014;20:579–87.
- Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013;5:CD000165.
- Gorin SS, Heck JE. Meta-analysis of the efficacy of tobacco counseling by health care providers. Cancer Epidemiol Biomarkers Prev. 2004;13:2012–22.
Source: PubMed